GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yonghe Medical Group Co Ltd (HKSE:02279) » Definitions » EV-to-EBITDA

Yonghe Medical Group Co (HKSE:02279) EV-to-EBITDA : -3.75 (As of Jun. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Yonghe Medical Group Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Yonghe Medical Group Co's enterprise value is HK$745 Mil. Yonghe Medical Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-199 Mil. Therefore, Yonghe Medical Group Co's EV-to-EBITDA for today is -3.75.

The historical rank and industry rank for Yonghe Medical Group Co's EV-to-EBITDA or its related term are showing as below:

HKSE:02279' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.93   Med: 6.64   Max: 30.98
Current: -3.75

During the past 7 years, the highest EV-to-EBITDA of Yonghe Medical Group Co was 30.98. The lowest was -7.93. And the median was 6.64.

HKSE:02279's EV-to-EBITDA is ranked worse than
100% of 498 companies
in the Healthcare Providers & Services industry
Industry Median: 12.1 vs HKSE:02279: -3.75

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-02), Yonghe Medical Group Co's stock price is HK$1.09. Yonghe Medical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.483. Therefore, Yonghe Medical Group Co's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Yonghe Medical Group Co EV-to-EBITDA Historical Data

The historical data trend for Yonghe Medical Group Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yonghe Medical Group Co EV-to-EBITDA Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial - 13.49 34.32 -8.43 5.94

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.32 - -8.43 - 5.94

Competitive Comparison of Yonghe Medical Group Co's EV-to-EBITDA

For the Medical Care Facilities subindustry, Yonghe Medical Group Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yonghe Medical Group Co's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Yonghe Medical Group Co's EV-to-EBITDA falls into.


;
;

Yonghe Medical Group Co EV-to-EBITDA Calculation

Yonghe Medical Group Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=744.574/-198.648
=-3.75

Yonghe Medical Group Co's current Enterprise Value is HK$745 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yonghe Medical Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-199 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yonghe Medical Group Co  (HKSE:02279) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Yonghe Medical Group Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.09/-0.483
=At Loss

Yonghe Medical Group Co's share price for today is HK$1.09.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yonghe Medical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.483.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Yonghe Medical Group Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Yonghe Medical Group Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Yonghe Medical Group Co Business Description

Traded in Other Exchanges
Address
20 Ganluyuan Nanli, China Nuclear E&C Building, 3A/F, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. It is principally engaged in the provision of hair transplant services, which are subject to similar types of services, similar classes of customers, similar regulatory environment, and similar business risk. The company generated the majority of its revenue from hair transplant services. It offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
Executives
Zhang Yu 2307 Founder of a discretionary trust who can infl
Cyh Cosmetic Medical Investment Limited
Pan Mao Shang Hai Tou Zi Zhong Xin You Xian He Huo
Shang Hai Pan Nuo Qi Ye Guan Li Fu Wu You Xian Gong Si
Zhong Xin Chan Ye Tou Zi Ji Jin Guan Li You Xian Gong Si
Zy Ventures Ltd
Zy Investment Capital Ltd
Yonghe Hair Service Holdings Limited
Cyh Cosmetic Medical Holdings Limited
Cpechina Fund Iia, L.p.
Cpechina Fund Ii, L.p.
Citron Pe Holdings Limited
Citron Pe Funds Ii Limited
Citron Pe Associates Ii, L.p.
Citic Securities Company Limited

Yonghe Medical Group Co Headlines

No Headlines